LoginSignup
Imagen de perfil
Bimbam
@Klambam
1Año·

Has anyone read news about $IBRX (-11,04 %) or knows what is going on? Almost 300% in one month.

1
11 Comentarios
Imagen de perfil
Patrick ₿ateman@fastlane
1Año
„NATIONAL MULTICENTER TRIAL OPENS TO STUDY IMMUNITYBIO'S TRI-AD5 CANCER
VACCINES PLUS N-803 TO PREVENT CANCER IN PEOPLE WITH LYNCH SYNDROME“ - Reuters
•
2
•
Imagen de perfil
Yassin@RisingAktie
1Año
Wanted to expand my position the other day when they were at just under € 2, but then they were already slowly shooting up again. Stupid timing until the money was on deposit :(
•
2
•
Imagen de perfil
Bimbam@Klambam
1Año
@RisingAktie Did not dare to buy again 😂
••
Imagen de perfil
Yassin@RisingAktie
1Año
@Klambam I thought the go down again briefly, but then it knew only one direction upwards and I wanted to reduce my buy-in actually and not increase. Well, I'm just now well back in the plus. Could only have been more, if I had decided 1-2 days earlier
••
Imagen de perfil
Bimbam@Klambam
1Año
@RisingAktie yes let's wait and see where the journey goes 💪🏻
•
1
•
Imagen de perfil
Nico@itZNico
1Año
"The increase in share prices is likely due to the positive momentum building around the company's lead pipeline candidate, N-803. The FDA is currently reviewing a regulatory submission for N-803 in combination with Bacillus Calmette-Guerin (BGC) for the treatment of patients with bladder cancer." Source: https://www.zacks.com/stock/news/2091284/immunitybio-ibrx-stock-jumps-432-will-it-continue-to-soar
•
1
•
Imagen de perfil
Bimbam@Klambam
1Año
@Clermit that did not run with as hoped. rebuy? 😂
•
1
•
Imagen de perfil
MarsEquities@CircusClown
1Año
@Klambam 😑das timing was of course pure comedy . Have been holding for ages and bought some more during and before the run and sold ~1/5 of the position at 5-6 again. Now again -40% all time with the rest . I personally buy rather between 1-1.5 after if it comes so far yet. Since there is no new date I suspect that it will take at least 3-6 months until the next decision, so it has for me no particular hurry to buy if it is not just again at the 52w low rumdümpelt. Of course only my personal opinion
•
2
•
Imagen de perfil
MarsEquities@CircusClown
1Año
What the others have already mentioned + general strength in biotech in recent weeks + insider buying in April by Soon-Shiong. IBRX was also sold off massively before that. YTD it is still "only" 22% up.
••
Imagen de perfil
MarsEquities@CircusClown
1Año
@Clermit shovel stocks is unfortunately no longer here but on his Twitter he regularly posts updates about IBRX.
•
2
•
Imagen de perfil
Bimbam@Klambam
1Año
@Clermit ah okay, thanks for the info 👍🏻
••
Únase a la conversación
InscríbaseInicio de sesión